Blueprint Medicines Stock News & Updates
[WKN: A14SDD | Symbol: 2L9]
Blueprint Medicines
Stocks in Action USA: Cleveland-Cliffs, Kymera Therapeutics, Blueprint Medicines
Weak US Industry and Trade Risks Weigh on Wall Street – Markets are Starting the Week With Losses - Trump's new Tariffs Make US Steel Stocks Explode – Numerous Biotech Stocks Benefit From Positive News - DAX Starts June With Losses – US Tariffs and Ukraine Conflict Weigh on Markets!
After a historic May rally, the start of June for the US stock markets is noticeably more restrained:...
Sanofi: Innovation Leader in Immunology Thanks to Blueprint Acquisition!
On Monday, Sanofi announced that it will acquire the US biopharmaceutical company Blueprint Medicines...
Blueprint Medicines: Multibillion-Dollar Opportunity Through Innovative Cancer Drugs
In particular, biopharmaceuticals targeting rare and difficult-to-treat diseases are of great importance...
- ‹
- 1
- ›